Nurix Therapeutics, Inc.: how funds voted at the meeting of 20 May 2024
- Ticker
- NRIX
- Meeting
- Season
- year to 30 June 2024
- Filers reporting
- 238
- Ballot items
- 3
238 filers on Form N-PX reported votes at the Nurix Therapeutics, Inc. meeting of 20 May 2024. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Nurix Therapeutics, Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2024. Filings read through . How the figures are made
The ballot
Item 1: Director elections
2 nominees. 49.9% of the reported votes are for. 54 filers withheld from or voted against at least one nominee.
357 vote records from 94 filers. 35 of the 91 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 34 fund families
- For 13
- Abstain or withhold 14
- Split or no vote 7
- Against management 14
Item 2: Advisory vote on executive pay (say-on-pay)
351 vote records from 238 filers. 105 of the 226 filers that marked the item voted against management. 12 filers gave no management mark.
- Positions of 41 fund families
- For 24
- Against 16
- Split or no vote 1
- Against management 16
Item 3: Audit-related items (auditor ratification)
179 vote records from 94 filers. 1 of the 91 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 34 fund families
- For 33
- Split or no vote 1
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Auditor |
|---|---|---|
| AllianceBernstein | For | No report |
| American Century | Against, against management | For |
| BlackRock and iShares | For | For |
| BNY Mellon | Against, against management | No report |
| Brighthouse Funds | For | For |
| Charles Schwab | For | For |
| Columbia Threadneedle | For | For |
| Dimensional | Against, against management | For |
| DWS | Against, against management | For |
| Equitable | For | For |
| Fidelity | For | For |
| Franklin Templeton | For | For |
| Global X | For | For |
| Goldman Sachs | For | For |
| Guggenheim and Rydex | Against, against management | For |
| Invesco | Against, against management | For |
| J.P. Morgan | Against, against management | No report |
| Jackson National funds | Against, against management | For |
| Janus Henderson | Against, against management | No report |
| John Hancock and Manulife | Against, against management | For |
| Lincoln Financial | For | For |
| MassMutual | For | For |
| MFS | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Against, against management | For |
| Nationwide | Against, against management | For |
| Natixis and Loomis Sayles | For | No report |
| Neuberger Berman | For | No report |
| Northern Trust and FlexShares | For | For |
| Nuveen and TIAA | For | For |
| Pacific Life funds | For | For |
| PGIM and Prudential | For | No report |
| Principal | Against, against management | For |
| ProShares and ProFunds | Against, against management | For |
| Russell Investments | Split | Split |
| SEI | For | For |
| State Street and SPDR | For | For |
| T. Rowe Price | For | For |
| Transamerica | For | For |
| Vanguard | For | For |
| Victory Capital | Against, against management | For |
| Voya | Against, against management | For |
Questions
- How many filers reported votes at the Nurix Therapeutics, Inc. meeting?
- 238 Form N-PX filers reported votes at the meeting of 20 May 2024. On say-on-pay, 105 of 226 filers that marked the item voted against management (46.5%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Nurix Therapeutics, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Nurix Therapeutics, Inc. with a meeting date within three days of 20 May 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .